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fication reaction, the erroneous template may be amplified to 
nearly as great an extent as the desired target. Additionally, 
methods of target amplification that require thermocycling 
require additional apparatus, and may preclude real-time 
s detection when the sensitivity of the detection means is itself 
affected by changes in temperature. 
Hammond et al., U.S. Pat. No. 6,255,051, taking a dif- 
ferent approach, recently described a “recursive cascade” of 
strand displacement reactions with gain of signal at each 
i o  individual displacement reaction, which is said to lead to 
signal amplification. However, the scheme requires at least 
seven engineered probe molecules for each target to be 
detected. 
There thus exists a continuing need in the art for methods, 
is devices, compositions and kits for amplifying the signal in 
nucleic acid hybridization reactions, and particularly for 
nonenzymatic, isothermal methods for amplifying the signal 
without physical amplification of target. 
20 SUMMARY OF THE INVENTION 
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NONENZYMATIC CATALYTIC SIGNAL 
AMPLIFICATION FOR NUCLEIC ACID 
HYBRIDIZATION ASSAYS 
STATEMENT OF GOVERNMENT SUPPORT 
This invention was made in the course of U.S. contract no. 
NAS2-99092 awarded by NASA. The U.S. government has 
certain rights in this invention. 
FIELD OF THE INVENTION 
The present invention is in the field of molecular biology, 
and relates particularly to devices, methods, and kits for 
amplifying signals from hybridization reactions between 
nucleic acid probes and their cognate targets. 
BACKGROUND OF THE INVENTION 
Efforts to increase the sensitivity of nucleic acid hybrid- 
ization reactions have been a recurrent feature of the 
molecular biology landscape for the past 30 years. Among 
other advantages, increases in sensitivity serve to decrease 
the amount of sample, probe, and other reagents required to 
detect a nucleic acid target, of particular importance when a 
biological sample occurs in limiting amount. 
Early efforts were directed to increasing detection sensi- 
tivity in hybridization reactions performed using radiola- 
beled probes and included, for example, the development of 
methods for increasing the specific activity of radiolabeled 
probes, such as random primed hexamer labeling, and of 
methods that increased detection sensitivity itself, such as 
the use of rare earth intensifying screens at subzero film 
exposure temperatures. The later introduction of phospho- 
rimaging techniques made possible the electronic amplifi- 
cation of radioactive signals. 
Other efforts, not limited to radioisotopic labeling, have 
included alterations in probe composition, such as use of 
single-stranded RNA transcripts, and more recently, the 
introduction of peptide nucleic acids, respectively reducing 
competition and increasing the stability of the resulting 
probe:target duplex. 
Enzymatic amplification of signal has also been used to 
increase sensitivity, with the enzyme variously catalyzing 
deposition of optically detectable colored product or, in the 
case of enhanced chemiluminescence, catalyzing the pro- 
duction of light. 
More recently, improvements in sensitivity have been 
attained by physical amplification of target, either before or 
during detection. The advantages of target 
amplification-including the ability to start with picomolar 
amounts of starting material, the ability to decrease the 
complexity of a sample by specific amplification of a desired 
sequence, and the ability to monitor amplification in real 
time-have led to a variety of amplification protocols, such 
as polymerase chain reaction (PCR), nucleic acid sequence- 
based amplification (NASBA), self-sustained sequence rec- 
ognition (3SR), ligase chain reaction (LCR), transcription- 
mediated amplification (TMA), rolling circle amplification 
(RCA), and strand displacement amplification (SDA). 
Yet all of these approaches have disadvantages. 
For example, there is a physical limit to the number of 
labels that can be incorporated into a probe of given length. 
Enzymatic methods for amplifying signal require careful 
attention to technique, and may require expensive reagents. 
Physical amplification of target suffers from nonspecific 
amplification; where mispriming occurs early in the ampli- 
The present invention solves these and other needs in the 
art by providing a simplified, two-step, strand displacement 
reaction protocol in which a target nucleic acid acts cata- 
2s lytically to amplify the signal resulting from its specific 
hybridization to a nucleic acid probe. The reaction is non- 
enzymatic and isothermal, and is readily adapted to a variety 
of labels and detection means. 
In a first aspect, the invention provides a device for 
30 nonenzymatically amplifying the signal from a hybridiza- 
tion reaction between at least a first nucleic acid probe and 
its cognate nucleic acid target present in fluid solvent. 
The device comprises at least one substrate; a first plu- 
rality of probe complexes, each having a probe nucleic acid 
35 strand and a displacement nucleic acid strand hybridized 
thereto, the plurality of probe strands being identical to one 
another and the plurality of displacement strands being 
identical to one another; and a first plurality of identical 
docking nucleic acid strands. 
The displacement strands and the docking strands are 
immobilized to one of the at least one substrates, the 
immobilized displacement strands and immobilized docking 
strands being spatially segregated from one another, sepa- 
rately addressable, and fluidly communicating upon contact 
45 of the device with fluid solvent. 
The probe strand of the probe complexes has at least three 
regions: a first region that is substantially complementary to 
a region of each of the displacement strand, the target, and 
the docking strand; a second region that is substantially 
50 complementary to a region of each of the target and the 
docking strand, but not substantially complementary to a 
region of the displacement strand; and a third region that is 
substantially complementary to a region of the docking 
strand, but not substantially complementary to a region of 
Contact of target to the device catalyzes transfer, by two 
successive strand displacement reactions, of the probe 
strands from their original address at the site of immobili- 
zation of the displacement strands, to a final address at the 
60 spatially segregated, separately addressable, site of attach- 
ment of the docking strands. The transfer of the probe 
generates a detectable signal. 
The substrate may be a unitary substrate, such as a 
substrate having a planar surface to which the displacement 
65 strands and docking strands are segregably attached. Alter- 
natively, the unitary substrate may be at least one internal 
wall of a capillary, channel, or chamber formed in the 
40 
5s either of the displacement strand or the target. 
3 
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device. The unitary substrate may, in illustrative embodi- 
ments, comprise glass, silicon, or plastic. 
The substrate may instead be nonunitary, such as a 
collection of beads, or electrodes of an electrode array, 
including a nanowire electrode array. 
The probe strands may optionally further comprise one or 
more signaling moieties, such as an optically detectable 
moiety, such as a fluorophore, an electrochemically detect- 
able signaling moiety, such as a polyguanidine polymer or 
ferrocenyl group, a radioactive moiety, or a moiety that is 
mass spectrally detectable. 
The displacement strand, probe strand, and displacement 
strand may be designed to tune the probe’s ability selec- 
tively to discriminate among polymorphic variants of the 
target. The device may be designed to discriminate targets 
that differ from one another by three or more nucleotides, 
two or more nucleotides, or even a single nucleotide (single 
nucleotide polymorphism). 
In these and other illustrative embodiments, the second 
and third regions of the probe strands may independently be 
2-14 nucleotides in length, 2-10 nucleotides in length, or 
even 2-6 nucleotides in length. 
In various embodiments, any or all of the probe strands, 
displacement strands, and docking strands may be peptide 
nucleic acids or include locked nucleic acid analogues. 
The devices of the present invention may be used to detect 
a single target, or a plurality of targets in a multiplexed 
reaction. 
To detect a plurality of targets, the device of the present 
invention further comprises at least a second plurality of 
probe complexes and at least a second plurality of docking 
strands. The displacement strands, probe strands, and dock- 
ing strands of the at least second pluralities are respectively 
identical thereamong but differ from those of the first 
plurality, and the first and second regions of the additional 
pluralities are substantially complementary to at least a 
second cognate nucleic acid target. 
In certain embodiments, the additional pluralities of probe 
strands are distinguishably labeled from the first plurality of 
probe strands, as by labeling with fluorophores having 
optically distinguishable excitation or emission spectra. 
In a second aspect, the invention provides a method of 
detecting a hybridization reaction between a nucleic acid 
probe and its cognate nucleic acid target with a catalytically 
amplified signal. 
The method comprises contacting the target, in a fluid 
solvent-for example, within an aqueous composition-to a 
device according to the present invention. In the device, the 
first and second regions of the probe strands are substantially 
complementary to the target and the target thus catalyzes 
transfer of the probe strand from its original address at the 
site of displacement strand immobilization to the spatially 
segregated, separately addressable, site of docking strand 
immobilization. The transfer of the probe generates a signal, 
which is then detected. 
The signal may be either or both of a diminution in probe 
concentration at its original address or an increase in probe 
concentration at the final address. In embodiments in which 
the probe strand is labeled, the signal may be either or both 
of a diminution in detectable signal at the original probe 
address or an increase in signal at the final probe address. 
The signal may be optically detectable, such as fluores- 
cence emission, electrochemically detectable, or mass spec- 
trally detectable. 
The detection methods of the present invention may 














sample and before detecting signal, of separating the immo- 
bilized docking strands from the fluid solvent. 
In a third aspect, the invention provides a kit for nonen- 
zymatically amplifying the signal from a hybridization reac- 
tion between at least a first nucleic acid probe and its cognate 
nucleic acid target present in fluid solvent. 
The kit comprises a device of the present invention having 
immobilized displacement strands and immobilized docking 
strands, but in which the probe strands have not been 
heteroduplexed to the displacement strands, and a compo- 
sition comprising such probe strands. Thus, the kit permits 
the device to be readied for use immediately before sample 
addition, obviating any instability of probe duplexes that 
might preclude long term storage of the amplification 
device. 
Accordingly, the kit comprises a device that comprises at 
least one substrate, a first plurality of identical displacement 
nucleic acid strands, and a first plurality of identical docking 
nucleic acid strands. The displacement strands and the 
docking strands are immobilized to one of the at least one 
substrates, the immobilized displacement strands and immo- 
bilized docking strands being spatially segregated from one 
another, separately addressable, and fluidly communicating 
upon contact of the device with fluid solvent. The kit further 
comprises a composition that comprises probe nucleic acid 
strands, the probe nucleic strands having at least three 
regions: a first region that is substantially complementary to 
a region of each of the displacement strand, the target, and 
the docking strand; a second region that is substantially 
complementary to a region of each of the target and the 
docking strand, but not substantially complementary to a 
region of the displacement strand; and a third region that is 
substantially complementary to a region of the docking 
strand, but not substantially complementary to a region of 
either of the displacement strand or the target. 
In some embodiments of the kits of the present invention, 
the probe strands are detectably labeled. In other embodi- 
ments, the kit further comprising reagents for detectably 
labeling the probe strands of the included composition. In 
yet other embodiments, the kit further comprises a control 
composition, the control composition including target 
nucleic acids, typically at defined concentration, that are 
capable of catalyzing transfer of the probes from the dis- 
placement strands of the device to the docking strands of the 
device. 
Further features of the invention, its nature and various 
advantages will be more apparent from the accompanying 
drawings and the following detailed description. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The above and other objects and advantages of the present 
invention will be apparent upon consideration of the fol- 
lowing detailed description, taken in conjunction with the 
accompanying drawings, in which like reference characters 
refer to like parts throughout, and in which: 
FIG. 1 shows an illustrative device for catalytically ampli- 
fying the signal from a hybridization reaction, according to 
the present invention; 
FIG. 2Ashows a first spontaneous reaction step following 
contact of the device of FIG. 1 with a target nucleic acid in 
an illustrative method of the present invention; 
FIG. 2B shows a second spontaneous reaction step fol- 
lowing contact of the device of FIG. 1 with a target nucleic 
acid in an illustrative method of the present invention; 
FIG. 3A summarizes the overall reaction, individual steps 
of which are shown in FIGS. 2A and 2B, particularly 
US 7,005,265 B1 
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demonstrating the catalytic action of the target nucleic acid 
in effecting probe transfer in an illustrative method of the 
present invention; and 
FIG. 3B illustrates the successively increased length of 
the duplexed region of the nucleic acid probe through the s 
reaction steps in an illustrative method of the present inven- 
tion. 
mide-containing conditions. By “cognate target” is intended 
a nucleic acid intended specifically to be detected by probe 
14; that is, a nucleic acid as to which probe 14 is sufficiently 
complementary as to permit its specific detection. 
Probe 14 is hybridized to displacement strand 12 in 
complex 18 by hybridization of probe region 14b’ to dis- 
placement region 14b, which is substantially complementary 
thereto. 
Probe strand regions 14c’ and 14d’, which are not sub- 
i o  stantially complementary to a region of displacement strand 
The present invention provides devices, methods, and kits 12, remain single-stranded in probe complex 18. 
for nonenzymatic, isothermal, catalytic amplification of the Docking strand 20 has at least three regions, 20b, 20c, and 
signal from a hybridization reaction between a nucleic acid 20d: region 20b is substantially complementary to probe 
probe and its cognate target. The amplified signal facilitates strand region 14b’; region 20c is substantially complemen- 
detection of a nucleic acid target. is tary to probe strand region 14c’; region 20d is substantially 
FIG. 1 schematizes an illustrative device for performing complementary to probe strand region 14d‘. 
an illustrative method of the present invention. FIGS. 2A-2C schematize an illustrative method of the 
Device 100 comprises substrate 10. As more fully present invention performed using the illustrative device of 
described below, substrate 10 is any substrate to which a FIG. 1. 
single-stranded nucleic acid may be attached, either 20 As shown in FIG. 2A, substrate-attached probe complex 
covalently or noncovalently. In the illustrative embodiment 18 is contacted with single-stranded target nucleic acid 
shown in FIG. 1, substrate 10 includes a planar surface to strand 22 in a fluid solvent, typically as an aqueous com- 
which nucleic acids are attached. position. 
Single-stranded nucleic acid 12, herein also called a Upon contact, target strand 22 displaces probe strand 14 
“displacement strand”, and single-stranded nucleic acid 20, 2s from probe complex 18. The displacement reaction creates 
herein also called a “docking strand”, are attached to sub- a fluidly mobile target complex 24, comprising target strand 
strate 10. Displacement strand 12 and docking strand 20 may 22 hybridized to probe strand 14, leaving displacement 
be attached to substrate 10 at their respective 3’ termini, 5’ strand 12 attached, in single-stranded form, to substrate 10 
termini, or via internal nucleotides. at its original address. 
Target strand 22 includes at least two regions: target 
that is spatially distinct and separately addressable from the region 22b, which is substantially complementary to probe 
site of attachment of displacement strand 12, and that can be strand region and target region 22c, which is substan- 
placed in fluid communication therewith. Although the sites tially complementary to probe strand region 14c‘. 
of attachment of displacement strand 12 and docking strand Displacement of probe strand 14 from displacement 
20 are shown in FIG. 1 as spatially segregated sites on a 3s strand 12 is initiated by the interaction of target region 22c 
unitary substrate 10, displacement strand 12 and docking with single-stranded probe region 14c’, which is substan- 
strand 20 may be attached to separate and discrete (i.e., tially complementary thereto. Completion of the displace- 
nonunitary) substrates 10, so long as the sites of attachment ment reaction is driven by the increased stability (lower 
are separately addressable and can be placed in fluid com- enthalpy) of target complex 24 as compared to probe com- 
munication with one another. 40 plex 18, which is in turn due to the increase in length of the 
For illustrative purposes, FIG. 1 shows a single displace- duplexed region of the probe in target complex 24: as 
ment strand 12 and a single docking strand 20. In typical schematized in FIG. 3B, the duplexed region in fluidly 
embodiments, however, a plurality of displacement strands mobile target complex 24 spans probe regions 14bt-14c’; by 
12, either identical to one another or different from one contrast, the duplexed region in original probe complex 18 
another, are attached to substrate 10. Similarly, a plurality of 4s traverses only probe region 14b‘. 
docking strands 20, either identical or nonidentical to one FIG. 2B shows a second reaction step. Fluidly mobile 
another, are typically attached to substrate 10. target complex 24 contacts docking strand 20. As more fully 
Single-stranded nucleic acid strand 14, herein also discussed below, target complex 24 may contact docking 
denominated the “probe strand”, is hybridized to displace- strand 20 by simple diffusion through the fluid phase of the 
ment strand 12 by Watson-Crick basepairing to form strand so hybridization reaction, or may contact docking strand 20 by 
displacement probe complex 18. movement that is further motivated by bulk fluid flow, 
Probe strand 14 comprises at least three regions: a first electrical field, or other external forces. 
region (region 14b’) that is substantially complementary to Docking strand 20 then displaces target strand 22 from 
a region of each of displacement strand 12, cognate target target complex 24. 
strand 22 (see FIGS. 2A and 2B), and docking strand 20; a ss Docking strand region 20d initiates displacement through 
second region (region 14c’) that is substantially complemen- interaction with probe single-stranded region 14d’. Comple- 
tary to a region of each of cognate target 22 and docking tion of the displacement reaction is driven by the increased 
strand 20, but that is not substantially complementary to a stability (lower enthalpy) of the resulting docking complex 
region of displacement strand 12; and a third region (region 26 as compared to target complex 24, which is attributable 
14d’) that is substantially complementary to a region of 60 to the longer span of duplex in the final docking complex: as 
docking strand 20, but not substantially complementary to a schematized in FIG. 3B, the duplexed region of docking 
region of either of displacement strand 12 or cognate target complex 26 spans probe regions 14bt-14c’-14d’; by contrast, 
strand 22. the duplexed region of fluidly mobile target complex 24 
By “substantially complementary” is intended a degree of spans only probe regions 14b’-14cr. 
sequence complementarity sufficient to provide a stable 65 The displacement reaction immobilizes probe 14 at the 
duplex under desired hybridization conditions, typically docking strand address, that is, at the site of attachment of 
high stringency or medium stringency aqueous or forma- docking strand 20 to substrate 10, and liberates target 22, 
DETAILED DESCRIPTION 
Docking strand 20 is attached to substrate 10 at any site 30 
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which is then free to contact a new probe complex 18 in a 
new iteration of the reaction set forth in FIGS. 2A and 2B. 
FIG. 3A summarizes the overall reaction, making explicit 
that target strand 22 acts catalytically to effect transfer of 
probe strand 14 from its original address at the site of 
substrate attachment of displacement strand 12 to the sub- 
strate attachment site of docking strand 20. The limiting 
substrates for the catalytic reaction are probe complexes 18 
and corresponding docking strands 20, and the reaction can 
continue until either one or both is exhausted. 
The transfer of the probe from its original to final address 
may generate a detectable signal at either or both of the 
displacement strand address or docking strand address. For 
example, probe strand 14 may be labeled, such as by 
attachment of optional signaling moiety 16, which may be 
coupled to probe strand 14 through optional linker 15. 
Accordingly, the presence of target may be detected by 
either or both of diminution of signal at the original probe 
address or increase of signal at the final probe address. 
Returning to FIG. 1, substrate 10 of device 100 may be 
any substrate to which a single-stranded nucleic acid may be 
attached, either covalently or noncovalently, in or upon 
which the sites of attachment may be separately addressed 
and placed in fluid communication with one another. 
Substrate 10 may be porous. For example, substrate 10 
may be a bibulous or nonbibulous membrane filter. Filters 
for nucleic acid attachment and detection are well known in 
the molecular biology, and include, for example, filters 
comprising nitrocellulose, nylon, or positively-charged 
derivatized nylon. 
Substrate 10 may, conversely, be nonporous, and may 
conveniently be a material commonly used for construction 
of nucleic acid microarrays, such as a glass slide, surface- 
derivatized glass slide, or silicon wafer, or may usefully 
comprise any of a variety of laboratory-grade plastics. 
Plastic substrates may usefully be selected from the group 
consisting of polymethylacrylic, polyethylene, polypropy- 
lene, polyacrylate, polymethylmethacrylate, polyvinylchlo- 
ride, polytetrafluoroethylene, polystyrene, polycarbonate, 
polyacetal, polysulfone, celluloseacetate, cellulosenitrate, 
nitrocellulose, and mixtures thereof. 
Substrate 10 may, but need not, be planar or include a 
planar surface. 
For example, device 100 of the present invention may 
conveniently be shaped as a cuvette, one or more internal 
surfaces of which serve as substrate 10. Alternatively, device 
100 of the present invention may include channels, cham- 
bers, or tubes-for example as parts of a microfluidic 
device-with one or more internal surfaces of such chan- 
nels, chambers, or tubes serving as substrate 10. Device 100 
may be shaped as a disc, such as an optical disc, with 
substrate 10 being one or more surfaces upon or within the 
disc, the spinning of the disc usefully serving to motivate 
fluid movement by centripetal force. 
Substrate 10 may be unitary, providing sites of attachment 
on a single substrate for both displacement strand 12 and 
docking strand 20. 
Substrate 10 may instead be nonunitary, distributing dis- 
placement strand 12 and docking strand 20 onto different 
substrates that are separately addressable and that, upon 
common contact with a fluid solvent, are placed in fluid 
communication with one another. 
Substrate 10 may, for example, be a surface of a bead, or 
pellet, such as a glass bead, with displacement strand 12 and 
docking strand 20 distributed onto different beads. The 
beads, in these embodiments, are separately addressable, 
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and can be placed in fluid communication with one another 
upon mutual contact with a fluid solvent. 
The beads need not be spherical. In addition, the beads 
may be porous, thus increasing the surface area of the bead 
s available for assay. Bead sizes usefully range from nanom- 
eters, e.g. 100 nm, to millimeters, e.g. 5 mm, usefully from 
about 0.2 micron to about 200 microns, with beads from 
about 0.5 to about 5 microns being typical. 
Suitable bead compositions include those used in peptide, 
i o  nucleic acid and organic moiety synthesis, and include, for 
example, plastics, such as polystyrene, methylstyrene, 
acrylic polymers, ceramics, glass, paramagnetic materials, 
titanium dioxide, latex, cross-linked dextrans, cellulose, and 
nylon. See, e.g., “Microsphere Detection Guide” (Bangs 
is Laboratories, Inc., http://www.bangslabs.com/products/ 
bangs/guide.php). 
In another illustrative example of nonunitary substrates 10 
in the devices of the present invention, device 100 may 
comprise an array of electrodes, with each separately addres- 
20 sable electrode presenting on its surface a substrate 10 onto 
which displacement strands 12 and docking strands 20 may 
distributably be attached. 
Arrays of nanowire electrodes, such as arrays of carbon 
nanotubes with covalently attached nucleic acids, and meth- 
zs ods for their manufacture, are described in commonly 
owned and copending application Ser. Nos. 101117,965, 
which is abandoned, and 101117,866, which issued as U.S. 
Pat. No. 6,831,017 on Dec. 14,2004, both filed Apr. 5,2002, 
and commonly owned provisional application Ser. No. 
30 601370,763, filed Apr. 5, 2002, the disclosures of which are 
incorporated herein by this reference in their entireties. 
Displacement strand 12 and docking strand 20 are 
attached to substrate 10 by covalent, noncovalent, or strong 
coordinate bond interactions. 
Covalent attachment may be effected, for example, by 
spotting an amine derivatized nucleic acid onto a silylated 
glass surface, followed by covalent bonding upon sodium 
borohydride reduction. In another illustrative approach, 
covalent attachment may be effected by contacting an amine 
40 derivatized nucleic acid to a substrate bearing surface epoxy 
groups. 
Noncovalent attachment may be direct or indirect. Direct 
noncovalent bonding may readily be effected, e.g., by spot- 
ting the nucleic acid onto a glass or derivatized glass surface 
4s in admixture with a chaotrope. Indirect noncovalent attach- 
ment may readily be accomplished by derivatizing the 
nucleic acid with one member of a specific binding pair, 
such as biotin, the other member of the binding pair, such as 
streptavidin, being attached to substrate 10. 
Nucleic acids may be attached by coordinate, or dative, 
bonding between, e.g., a thiolated nucleic acid and a gold or 
platinum substrate 10. 
Other methods of attaching nucleic acids to support 
surfaces are well known in the art. 
Displacement strand 12, immobilized to substrate 10, 
hybridizes to probe strand 14, which is not attached to 
substrate 10, to create a partially duplexed strand displace- 
ment probe complex 18. The duplexed region is formed 
between displacement strand region 12b and substantially 
Displacement strand 12 may further comprise additional 
regions, such as region 12a as shown in FIG. 1, that are not 
substantially complementary to regions of probe 14. The one 
or more additional regions of displacement strand 12 may be 
65 disposed more proximally to substrate 10 than is region 12b, 
as illustrated, or may be disposed more distally to substrate 




60 complementary probe region 14b‘. 
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Region 12b of displacement strand 12 may be as short as 
15 nucleotides in length, 20 nucleotides in length, or even as 
short as 25 nucleotides in length. Region 12b may be greater 
than 25 nucleotides in length, including at least 50 nucle- 
otides in length, 75 nucleotides in length, even 100 nucle- 
otides in length or more, such as 250 nucleotides, 500 
nucleotides, even 1000 nucleotides or more in length, 
although lengths of 25 -250 nt are more typical. 
Displacement strand 12 as a whole may be as short as 15 
nucleotides in length, 20 nucleotides in length, or even as 
short as 25 nucleotides in length, particularly when displace- 
ment strand 12 lacks regions additional to region 12b. More 
typically, displacement strand 12 may be greater than 25 
nucleotides in length, including at least 50 nucleotides in 
length, 75 nucleotides in length, even 100 nucleotides in 
length or more, such as 250 nucleotides, 500 nucleotides, 
even 1000 nucleotides or more in length, although lengths of 
25 -250 nt are more typical. 
Additional considerations that may be used in designing 
the size and sequence of displacement strand 12 are further 
described below. 
Probe region 14b’, which is substantially complementary 
to displacement strand region 12b, may be as short as 15 
nucleotides in length, 20 nucleotides in length, or even as 
short as 25 nucleotides in length. Probe region 148 may be 
greater than 25 nucleotides in length, including at least 50 
nucleotides in length, 75 nucleotides in length, even 100 
nucleotides in length or more, such as 250 nucleotides, 500 
nucleotides, even 1000 nucleotides or more in length, 
although lengths of 25 -250 nt are more typical. 
Probe regions 14c’ and 14d’ may each independently be as 
short as 2 nucleotides (nt), 3 nt, 4 nt, 5 nt, 6 nt, 7 nt, 8 nt, 
9 nt, even 10 nt. Region 14c’ may be greater than 10 nt, such 
as 11 nt, 12 nt, 13 nt, 14 nt, 15 nt, 16 nt, even 20 nt, 25 nt, 
30 nt, 40 nt, 50 nt or even longer. 
Probe regions 14b’ and 14c’, which are substantially 
complementary to target regions 22b and 22c, may be 
contiguous to one another in probe 14, as illustrated in FIGS. 
2A and 2B. However, such geometry is not required. Probe 
region 14d’, which is complementary only to region 20d of 
docking strand 20, may be contiguous to probe regions 148 
and 14c’, as shown in FIGS. 2A and 2B, but such geometry 
is not required. 
Probe 14 may further include nucleic acid regions addi- 
tional to regions 14b’, 14c’, and 14d’, which regions are not 
substantially complementary to any one or more of displace- 
ment strand 12, target strand 22, or docking strand 20. Such 
additional regions may be located at either end of probe 14, 
or may be interposed between or among any of probe 
regions 14b’, 14c’, and 14d‘. 
Probe strand 14 may also be labeled, as by inclusion of an 
optional signaling moiety 16 (also termed a “label”), option- 
ally attached via a linker 15. 
Probe strand 14 may, for example, have an optically 
detectable label, a mass spectrally detectable label, a label 
detectable by electrochemical means, or a radioactive label. 
Optically detectable labels include moieties that fluoresce, 
moieties that luminesce, moieties that phosphoresce, and 
moieties that provide optically detectable calorimetric 
changes. 
Fluorescent labels for nucleic acid detection are well 
known in the art, and include, for example, CyDyesTM, such 
as Cy3, Cy3B, Cy3.5, Cy5, Cy5.5, Cy7 (Amersham Bio- 
sciences, Inc., Piscataway, N.J.), fluorescein isothiocyanate 
(FITC), Texas RedTM (Molecular Probes, Eugene, Oreg.), 
and Alexa Fluor dyes, such as Alexa Fluor 350, 430, 488, 
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532,546,568,594,633,647,660,680,700 and Alexa Fluor 
750 dyes (all from Molecular Probes, Eugene, Oreg.). 
Luminescent labels, such as enhanced chemilumines- 
cence labels, are well known in the art. For example, in the 
s presence of hydrogen peroxide (H202), horseradish peroxi- 
dase (HRP) can catalyze the oxidation of cyclic diacylhy- 
drazides, such as luminol; the luminol excited state then 
decays to the ground state by emitting light. Strong enhance- 
ment of the light emission is produced by enhancers, such as 
i o  phenolic compounds. Advantages include high sensitivity, 
high resolution, and rapid detection without radioactivity. 
See, e.g., Thorpe et al., Methods Enzymol. 133:331-53 
(1986); Kricka et al., J .  Immunoassay 17(1):67-83 (1996); 
and Lundqvist et al., J .  Biolumin. Chemilumin. 
is 10(6):353-359 (1995), the disclosures of which are incor- 
porated herein by reference in their entireties. Kits for such 
chemiluminescent and enhanced chemiluminescent detec- 
tion of nucleic acids are commercially available. 
Colorimetrically detectable labels include enzymes that 
20 can lead to local precipitation of optically-detectable colored 
products; such enzymes may be conjugated directly to probe 
14 or, more typically, through a second step interaction 
mediated by members of a specific binding pair, such as 
biotin, which is readily incorporated into nucleic acids, and 
zs streptavidin, which can readily be conjugated to enzymes. 
Enzymes useful for calorimetric detection are well 
known, and include alkaline phosphatase, 0-galactosidase, 
glucose oxidase, horseradish peroxidase (HRP), and urease. 
Typical substrates for production and deposition of visually 
30 detectable products include o-nitrophenyl-beta-D-galacto- 
pyranoside (ONPG); o-phenylenediamine dihydrochloride 
(OPD); p-nitrophenyl phosphate (PNPP); p-nitrophenyl- 
beta-D-galactopyranoside (PNPG); 3’,3’-diaminobenzidine 
(DAB); 3-amino-9-ethylcarbazole (AEC); 4-chloro-1-naph- 
3s tho1 (CN); 5-bromo-4-chloro-3-indolyl-phosphate (BCIP); 
ABTSB; BluoGal; iodonitrotetrazolium (INT); nitroblue 
tetrazolium chloride (NBT); phenazine methosulfate (PMS); 
phenolphthalein monophosphate (PMP); tetramethyl benzi- 
dine (TMB); tetranitroblue tetrazolium (TNBT); X-Gal; 
Labels that are detectable by mass spectrometry, “mass 
tags”, may also be used. Mass tags can be designed to 
provide hundreds of mass spectrally distinguishable species, 
allowing highly multiplexed reactions, and can be designed 
4s to be cleavable, typically photochemically cleavable, from 
the labeled nucleic acid, simplifying analysis. For nucleic 
acid hybridization assays, mass tags can provide quantita- 
tive, femtomolar sensitivity. See, e.g., Kokoris et al., Mol 
Diagn. 5(4):329-40 (2000). The mass of the probe itself may 
SO alternatively be detected, with or without an additional 
signaling mass attached thereto, for example by surface 
plasmon resonance techniques. 
Electrochemical signaling moieties include, for example, 
polyguanidine nucleic acid polymers and molecules com- 
Either or both of displacement strand 12 and docking 
strand 20 may also optionally be labeled. 
For example, when probe 14 is labeled with a fluorophore, 
either or both of displacement strand 12 and docking strand 
60 20 may be labeled with one or more fluorophores capable of 
fluorescence energy resonance transfer (FRET) with the 
fluorophore of probe 14. 
Pairs of fluorophores useful for FRET are well known in 
the art, and include, e.g., fluorescein isothiocyanate (FITC) 
65 and tetramethylrhodamine isothiocyanate (TRITC); FITCi 
Texas RedTM (Molecular Probes, Inc.); FITCiN-hydroxysuc- 
cinimidyl 1-pyrenebutyrate (PYB); FITCieosin isothiocyan- 
40 X-Gluc; and X-Glucoside. 
ss prising a ferrocenyl moiety. 
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ate (EITC); FITCItetramethylrhodamine (TAMRA); and rality of displacement strands being identical, and a first 
various Alexa Fluor pairs (Molecular Probes, Inc.), such as plurality of docking nucleic acid strands, the plurality of 
Alexa Fluor 488 and any one of Alex Fluors 546,555,568, docking strands being identical to one another. Such a 
594, or 647. plurality facilitates signal amplification by (and thus detec- 
When probe 14 is labeled with a fluorophore, either or s tion of) a single species of target 22 (or genus of targets 22 
both of displacement strand 12 and docking strand 20 may commonly possessing regions 22b and 22c). 
instead optionally be labeled with a fluorescence quencher. Device 100 may include at least 10 probe complexes 18, 
Conversely, probe 14 may be labeled with a fluorescence at least 50 probe complexes 18, at least 100 probe complexes 
quencher and either or both of displacement strand 12 and 18, at least 1000 probe complexes 18, even as many as 
docking strand 20 may be labeled with a fluorophore. i o  10,000, 50,000, or 100,000 probe complexes 18. Probe 
Suitable fluorophore-quencher pairs are well known in the complexes 18 may be disposed on substrate 10 of device 100 
art, and include, e.g., FAM, HEX, TAMRA, EDANS and at a density of l/pm2-10111pm2. 
Texas RedTM as fluorophore, with dabcyl useful as a com- Device 100 may also include at least a second plurality of 
mon quencher. Other quenchers include, e.g., QSY 7, QSY probe complexes and a second plurality of docking strands, 
9, QSY 21 and QSY 35 (all from Molecular Probes, Inc., is in which the displacement strands of the second plurality are 
Eugene, Oreg.); gold nanoparticles (Dubertret et al., Nature respectively identical to one another but different from the 
Biotechnol. 19:365-370 (2001)), and other metals and met- displacement strands of the first plurality; in which the probe 
alloids, both as macroscopic solids and nanoparticles, strands of the second plurality are respectively identical to 
including particles in colloid suspension. one another but different from those of the first plurality; and 
Displacement strand 12, probe strand 14, and docking 20 in which the docking strands are respectively identical to 
strand 20 comprise nucleic acids. one another but different from those of the first plurality. 
The nucleic acid may be a natural nucleic acid comprising Such additional pluralities of probe complexes (with 
natural nucleotides in natural 5’-3’ phosphodiester linkage, corresponding pluralities of docking strands) permit concur- 
such as DNA or RNA, or chimeras thereof, or may instead rent, multiplexed, amplification of signal by (and thus detec- 
be a nonnatural nucleic acid analogue, comprising one or zs tion of) additional species of target 22. 
more of modified bases, modified sugars, or modified link- Each of the pluralities of probe complexes 18 may be 
ages. A wide variety of nucleic acid analogues, and chem- distinctly labeled. For example, in an illustrative device of 
istries for their synthesis, are now well known in the the present invention, each of the distinct species of probe 
molecular biological art. See, e.g., Verma et al., “ Modified strand 14 may be labeled with a distinct fluorophore, the 
oligonucleotides: synthesis and strategy for users,” Annu. 30 distinct fluorophores having optically distinguishable exci- 
Rev. Biochem. 67:99-134 (1998) and Lyer et al., “Modified tation andlor emission spectra. 
oligonucleotides-synthesis, properties and applications,” Device 100 may include as few as 1, 5, or 10 distinct 
Cum Opin. Mol. Thev. 1(3):344-58 (1999), the disclosures species of probe complex and corresponding docking strand, 
of which are incorporated herein by reference in their each present as a plurality thereof. Device 100 may include 
entireties. 3s as many as 50, 100, 1,000, 5,000, 10,000, 100,000 even 
Among nucleic acid analogues that may be used for any 500,000 distinct species of probe complex and docking 
or all of the displacement strand, probe strand, or docking strand, each plurally present in the device. 
strand in the devices, methods and kits of the present As shown in FIG. 3A, the device and method of the 
invention are peptide nucleic acids (PNA). In PNA com- present invention cause target nucleic acid 22 to act as a 
pounds, the phosphodiester backbone of the nucleic acid is 40 catalyst in the transfer of probe 14 from its initial location at 
replaced with an amide-containing peptide backbone; the site of attachment of displacement strand 12 to the site 
nucleobases are bound directly or indirectly to aza nitrogen of attachment of docking strand 20. The signal resulting 
atoms of the amide portion of the backbone, typically by from such transfer is thus catalytically amplified. The extent 
methylene carbonyl linkages. See, e.g., Nielsen, Cum Opin. of signal amplification depends upon the amount of sub- 
Biotechnol. 12(1):16-20 (2001), the disclosure of which is 4s strate, i.e. probe complexes 18 and docking strands 20 of 
incorporated herein by reference in its entirety. 
Also particularly useful are locked nucleic acid (LNA) 
analogues. LNAs are bicyclic and tricyclic nucleoside and 
nucleotide analogues and the oligonucleotides that contain 
such analogues. The basic structural and functional charac- 
teristics of LNAs and related analogues are disclosed in 
various publications and patents, including WO 99114226, 
WO 00156748, WO 00166604, WO 98139352, U.S. Pat. No. 
6,043,060, and U.S. Pat. No. 6,268,490, all of which are 
incorporated herein by reference in their entirety. See also, 
Braasch et al., “Locked nucleic acid (LNA): fine-tuning the 
recognition of DNA and RNA,” Chem. Biol. 8(1):1-7 
(2001), incorporated herein in its entirety by reference. 
Although a single displacement strand 12 and single 
docking strand 20 may be attached to substrate 10 of device 
100, signal amplification requires catalytic target recycling, 
appropriate sequence, the time required for a single reaction 
cycle, and the elapsed time prior to detection (number of 
reaction cycles). 
The devices and methods of the present invention may be 
SO used to amplify the signal by at least two-fold, 3-fold, 4-fold, 
even at least five-fold, 10-fold, 50-fold, 100-fold, 1000-fold, 
and even as much as 10,000-fold to 100,000 fold or more 
over the signal obtainable in an assay in which a probe with 
regions identical to regions 14b’ and 14c’ hybridizes to 
ss single-stranded target 22 without strand displacement. The 
reaction may be carried out under conditions in which the 
signal is amplified by a factor of lo6,  lo7, even los, lo9, or 
as much as 101’-fold. 
The devices and signal amplification methods of the 
60 present invention may be used to facilitate detection of 
nucleic acid targets in samples suspected of containing the 
which in turn requires a plurality of probe complexes 18 and target nucleic acid. 
docking strands 20 capable of interacting with target 22. Target nucleic acid may be detected in a fluid sample by 
Accordingly, device 100 may comprise a first plurality of contacting the sample to device 100, wherein the first and 
probe complexes, each having a probe nucleic acid strand 65 second regions of the probe strands of the device (regions 
and a displacement nucleic acid strand hybridized thereto, 14b’ and 14c’, respectively) are substantially complementary 
the plurality of probe strands being identical and the plu- to the target, and the first, second and third regions of the 
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probe strand (regions 14b', 14c' and 14d', respectively) are 
substantially complementary to the docking strand. Target 
nucleic acid present in the fluid sample catalyzes transfer of 
the probe strand from the immobilized displacement strand 
to the spatially segregated, separately addressable, immobi- 
lized docking strand. 
Target may then be detected as either or both of a 
diminution of probe concentration at its original address (the 
site of attachment of displacement strand 12) or increase in 
probe concentration at the final address (the site of attach- 
ment of docking strand 20). 
When probe 14 is labeled, target may be detected by 
detecting either or both of loss of signal at the original probe 
address or gain of signal at the final probe address. Detecting 
both the loss of signal at the original address and gain of 
signal at the final address may be used to increase the 
signa1:noise ratio or to increase sensitivity of the assay. 
Detection may be performed continuously, monitoring 
either or both of the decrease in signal at the displacement 
strand address or increase in signal at the docking strand 
address, or may be performed discretely at one or more 
desired times during the reaction or after its completion. 
In other embodiments of the detection methods of the 
present invention, after target-mediated catalytic transfer of 
probe strands to the docking strand address, the immobilized 
docking strands 20 and docking complexes 26 may be 
separated from the fluid medium before detection. Such 
inhomogeneous phase assays may have advantages when 
labeled probe strands provide an unacceptable level of 
background signal. 
Target nucleic acid may be any naturally occurring 
nucleic acid, such as DNAor RNA, or may be a nucleic acid 
derived therefrom, such as cDNA. Target may be single- 
stranded or double-stranded. When double-stranded, target 
is typically first denatured, as by application of heat or base 
such as NaOH. 
Sample is contacted to device 100 under conditions 
suitable for the successive strand displacement reactions 
shown in FIGS. 2A and 2B. 
Such conditions are well known in the art, and may 
readily and usefully be adapted from conditions established 
for standard hybridization reactions on analogous substrates. 
For example, when substrate 10 is one used in microarray 
hybridizations, such as a glass slide, hybridization condi- 
tions may readily and usefully be adapted from microarray 
hybridization conditions. For example, standard high strin- 
gency microarray conditions for spotted cDNA microarrays 
may be 50% formamide, SxSSC, 0.2 pg/pl poly(dA), and 
0.5% SDS at 42" C., followed by successive washes of the 
microarray in IxSSC, 0.2% SDS at 55" C. for 5 minutes, and 
then O.lxSSC, 0.2% SDS, at 55" C. for 20 minutes. Lower 
stringency conditions may usefully be the same as the high 
stringency conditions but with reduction in temperature for 
hybridization and washing, e.g. to room temperature (ap- 
proximately 25" C.). 
Hybridization may be conducted in the presence of 
hybridization enhancers, such as cetyltrimethylammonium 
bromide (CTAB), volume excluders, and nonspecific com- 
petitor nucleic acids, and at temperatures ranging from 20" 
C.-80" C., as is well known in the art. 
Further adjustments in hybridization reaction conditions 
are well within the skill in the art. 
The methods of the present invention provide a variety of 
advantages over other methods for amplifying signal and 
detecting a target nucleic acid. These advantages render the 
methods of the present invention well suited for field use, as 
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in environmental detection and monitoring, and in point of 
care clinical use, including home use. 
By effecting a substantial amplification in hybridization 
signal, the device and methods of the present invention may 
s obviate the need for physical amplification of target prior to 
detection, as by polymerase chain reaction (PCR), nucleic 
acid sequence-based amplification (NASBA), self-sustained 
sequence recognition (3SR), ligase chain reaction (LCR), 
transcription-mediated amplification (TMA), rolling circle 
i o  amplification (RCA), or strand displacement amplification 
(SDA). 
By obviating the need for physical amplification of target, 
the present invention reduces the number of steps the user 
must perform before detection is effected, reducing hands- 
is on assay time, manipulations that may introduce error, and 
opportunities for sample loss, and also obviates the need for 
the user to obtain oligonucleotide primers. 
In addition, by obviating the need for physical amplifi- 
cation of target, the present invention also eliminates the 
20 problem of nonspecific target amplification that attends such 
enzymatic methods, a problem even when physical ampli- 
fication is performed using proofreading enzymes, such 
polymerases having 3'-5' exonuclease activity. 
Because the methods of the present invention may be 
zs practiced at a single reaction temperature, the device and 
methods of the present invention obviate the need for 
thermocycling, and thus the need for apparatus capable of 
performing such cycling. The isothermal nature of the 
present reaction may be particularly advantageous when 
The methods of the present invention further obviate the 
need to label target nucleic acids, further reducing the 
number of manipulations required by the user. 
In a variety of embodiments of the methods of the present 
3s invention, no separation of components is needed before 
detection, providing a homogeneous phase assay. Homoge- 
neous phase assays are particularly well suited for field use, 
particularly by individuals lacking extensive training in 
laboratory arts. 
The spatial component of the signal in the methods of the 
present invention provides further advantages. 
For example, the transfer of probe from a first location to 
a second location may be used to distinguish spurious 
signals from true analyte-specific signals. Because true 
4s analyte-specific signals in the methods of the present inven- 
tion necessarily couple the diminution of signal at a first 
address to an increase of signal at a second address, mea- 
suring both signals permits such signals to be distinguished 
from background, increasing the signa1:noise ratio. 
Alternatively, the spatial component of the signal may be 
exploited, by summing the absolute value of the signal 
changes at the two locations, to increase sensitivity of the 
assay. 
Another advantage of the device and methods of the 
ss present invention is that the signal is a characteristic of the 
engineered probe strand, not of a labeled biological target, 
permitting the probe strand to be engineered to give an 
optimal, and characteristic, signal. For example, if electro- 
chemical detection is employed, probe strand 14 may be 
60 engineered to provide a characteristic signal at a predeter- 
mined redox potential. 
Analogously, probe strand 14, displacement strand 12, 
and docking strand 20 may readily be engineered to provide 
optimal reaction kinetics. For example, where a plurality of 
65 different probe complexes 18 (with correspondingly differ- 
ent docking strands 20) are used concurrently to detect a 
plurality of target species 22, the nucleic acids of device 100 
30 detection is made electrochemically. 
40 
SO 
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may be engineered to permit optimal strand displacement the immobilized docking strands being spatially segregated 
with a single, common, set of hybridization conditions, from one another, separately addressable, and fluidly com- 
facilitating multiplex analysis. municating upon contact of the device with fluid solvent. 
In addition, strand displacement reactions provide high The kit further comprises a composition comprising probe 
specificity and selectivity. As set forth in detail in commonly s nucleic acid strands suitable for completion of the device. 
owned U.S. patent application Ser. No. 101178,682, filed Accordingly, the probe nucleic strands have at least three 
Jun. 20, 2002, incorporated herein by reference in its regions: a first region that is substantially complementary to 
entirety, the use of strand displacement complexes permits a region of each of the displacement strand, the cognate 
the selectivity of nucleic acid probes for polymorphic vari- target, and the docking strand; a second region that is 
ants of their cognate targets to be adjusted, or “tuned”, i o  substantially complementary to a region of each of the 
without compromising target specificity. cognate target and the docking strand, but not substantially 
To effect such selectivity, probe strand 14 is duplexed complementary to a region of the displacement strand; and 
within probe complex 18 across at least one region (region a third region that is substantially complementary to a region 
12b’) as to which target selectivity is desired to be tuned. of the docking strand, but not substantially complementary 
Within the complex, probe strand 14 further has at least one is to a region of either of the displacement strand or the 
region (region 1 2 4  that is not duplexed by displacement cognate target. 
strand 12, and is complementary to target 22 but as to which The user desiring to amplify the signal from a nucleic acid 
target selectivity is not desired to be tuned. hybridization reaction between probe and cognate target 
The relative lengths and positions of these two probe hybridizes the probe to the displacement strands of the 
regions within probe complex 18 serve to adjust the pro- 20 device, taking care not to apply the probes to the docking 
portional effect of a mismatch on the overall free energy strands of the device, and then performs the assay by 
change of the displacement reaction, and thus tunes the contacting a fluid sample containing, or suspected to con- 
selectivity of the probe for polymorphic variants of the tain, the cognate target to the device so completed. 
target. The probe strands of the composition may be detectably 
Probe selectivity may be tuned to distinguish target vari- zs labeled, or the kit may further comprise reagents for detect- 
ants that differ in sequence by as few as two nucleotides, and ably labeling the probe strands of the composition. 
even by as few as one nucleotide. The kit may additionally comprise a control composition, 
The ability to tune the selectivity of longer probes for the control composition comprising target nucleic acids 
polymorphic variants of the probe’s cognate target can be capable of catalyzing transfer of the probes from the dis- 
exploited to improve methods of detecting polymorphic 30 placement strands of the device to the docking strands of the 
variants of a target, including single nucleotide polymor- device. 
phisms (SNPs). All patents, patent publications, and other published ref- 
In the methods of the present invention, the specificity and erences mentioned herein are hereby incorporated by refer- 
selectivity of strand displacement is independently effected ence in their entireties as if each had been individually and 
with each reaction cycle, in contrast to physical target 3s specifically incorporated by reference herein. 
amplification techniques, such as PCR, in which mispriming Although illustrative embodiments of the present inven- 
in an early cycle provides template that is further amplified tion are described above, it will be evident to one skilled in 
in successive cycles. the art that various changes and modifications may be made 
As a result, in the methods of the present invention signal without departing from the spirit and scope of the invention. 
is particularly amplified for the desired target, increasing the 40 Many examples of such modifications have been given 
specificity of the assay. through the foregoing specification. It is intended that the 
The methods of the present invention may usefully be appended claims cover all such changes and modifications 
practiced using nanoscale devices, thus reducing the time that fall within the true spirit and scope of the invention. 
required for diffusion of probe strand 14 to docking strand 
20. 4s 1. A device for nonenzymatically amplifying the signal 
In addition, the movement of probe strand 14 may be from a hybridization reaction between at least a first nucleic 
further facilitated by bulk fluid flow, as may be imposed, acid probe and its cognate nucleic acid target present in fluid 
e.g., by centripetal forces, by electrical fields, by electroos- solvent, the device comprising: 
mosis, and bv other microfluidic techniques. International 
What is claimed is: 
patent publications WO 00179285, WO 00178455, WO SO 
00169560, and WO 98153311, incorporated herein by refer- 
ence in their entireties, describe devices and methods for 
using centripetal acceleration to drive fluid movement in a 
microfluidics system; international patent applications num- 
bers WO 01147638 and WO 01146465, incorporated herein ss 
by reference in their entireties, describe rotatable discs 
having integrated microfluidics. 
In another aspect, the present invention provides kits for 
amplifying the signal from hybridization of a nucleic acid 
In an illustrative embodiment, a kit of the present inven- 
tion comprises a device, the device comprising: (i) at least 
one substrate; (ii) a first plurality of identical displacement 
nucleic acid strands; and (iii) a first plurality of identical 
docking nucleic acid strands. The displacement strands and 65 
the docking strands are immobilized to one of the at least 
one substrates, the immobilized displacement strands and 
probe to its cognate target. 60 
- -  
at least one substrate; 
a first plurality of probe complexes, each having a probe 
nucleic acid strand and a displacement nucleic acid 
strand hybridized thereto, the plurality of probe strands 
being identical and the plurality of displacement 
strands being identical; and 
a first plurality of identical docking nucleic acid strands, 
wherein the displacement strands and the docking strands 
are immobilized to one of said at least one substrates, 
said immobilized displacement strands and said immo- 
bilized docking strands being spatially segregated from 
one another, separately addressable, and fluidly com- 
municating upon contact of said device with fluid 
solvent, 
wherein the probe strand of said probe complexes has at 
least three regions, 
a first region that is substantially complementary to a 
region of each of the displacement strand, the target, 
and the docking strand; 
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a second region that is substantially complementary to 
a region of each of the target and the docking strand, 
but not substantially complementary to a region of 
the displacement strand; and 
a third region that is substantially complementary to a s 
region of the docking strand, but not substantially 
complementary to a region of either of the displace- 
ment strand or the target, 
whereby contact of target to said device is capable of 
catalyzing transfer of probe strands from the displace- i o  
ment strands to the spatially segregated, separately 
addressable docking strands, the transfer of said probe 
generating a detectable signal. 
2. The device of claim 1, wherein said at least one 
3. The device of claim 2, wherein said unitary substrate 
has a substantially planar surface to which said displacement 
strands and docking strands are segregably attached. 
4. The device of claim 2, wherein said unitary substrate is 
at least one internal wall of a capillary, channel, or chamber 20 
formed in said device. 
5. The device of either of claim 3 or 4, wherein said 
substrate comprises glass, silicon, or plastic. 
6. The device of claim 1, wherein said at least one 
7. The device of claim 1, wherein said probe strands 
further comprise a signaling moiety. 
8. The device of claim 7, wherein said signaling moiety is 
optically detectable. 
9. The device of claim 8, wherein said signaling moiety is 30 
a fluorophore. 
10. The device of claim 7, wherein said signaling moiety 
is electrochemically detectable. 
11. The device of claim 10, wherein said signaling moiety 
is a polyguanidine polymer. 
12. The device of claim 10, wherein said signaling moiety 
includes a ferrocenyl group. 
13. The device of claim 7, wherein said signaling moiety 
is radioactive. 
14. The device of claim 1, wherein either or both of the 
second and third regions of said probe strands is indepen- 
dently 2-14 nucleotides in length. 
15. The device of claim 14, wherein either or both of the 
second and third regions of said probe strands is indepen- 4s 
dently 2-10 nucleotides in length. 
16. The device of claim 15, wherein either or both of the 
second and third regions of said probe strands is indepen- 
dently 2-6 nucleotides in length. 
strands, said displacement strands, and said docking strands 
are peptide nucleic acids. 
18. The device of claim 1, wherein any or all of said probe 
strands, said displacement strands, and said docking strands 
19. The device of claim 1, further comprising a second 
plurality of probe complexes and a second plurality of 
docking strands, 
wherein the displacement strands, probe strands, and 
docking strands of said second pluralities are respec- 60 
tively identical thereamong but differ from those of said 
first plurality, and said probe strand first and second 
regions are substantially complementary to a second 
nucleic acid target. 
20. The device of claim 19, wherein said second plurality 65 
substrate is a unitary substrate. 1s 
substrate is an array of electrodes. 2s 
3s 
40 
17. The device of claim 1, wherein any or all of said probe so 
include locked nucleic acid analogues. 5s 
of probe strands are distinguishably labeled from said first 
plurality of probe strands. 
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21. The device of claim 20, wherein said first and second 
plurality of probe strands are respectively labeled with a first 
and second fluorophore, said first and second fluorophore 
having optically distinguishable excitation or emission spec- 
tra. 
22. A method of detecting a hybridization reaction 
between a nucleic acid probe and its cognate nucleic acid 
target with a catalytically amplified signal, the method 
comprising: 
contacting the target in a fluid solvent to a device accord- 
ing to claim 1, 
wherein the first and second regions of the probe 
strands of said device are substantially complemen- 
tary to said target and said target catalyzes transfer of 
the probe strand from the immobilized displacement 
strand to the spatially segregated, spatially address- 
able, immobilized docking strand, the transfer of said 
probe generating a detectable signal; and then 
23. The method of claim 22, wherein said signal is 
detected as a diminution of signal at the displacement strand 
address. 
24. The method of claim 22, wherein said signal is 
detected as an increase of signal at the docking strand 
address. 
25. The method of claim 22, wherein said signal is 
detected both as a diminution of signal at the displacement 
strand address and increase of signal at the docking strand 
address. 
26. The method of claim 22, wherein the signal is opti- 
cally detectable. 
27. The method of claim 26, wherein the signal is fluo- 
rescent. 
28. The method of claim 22, wherein the signal is elec- 
trochemically detectable. 
29. The method of claim 22, wherein the signal is mass 
spectrally detectable. 
30. The method of claim 22, further comprising the step, 
after contacting and before detecting, of  
separating the immobilized docking strands from said 
31. Akit for nonenzymatically amplifying the signal from 
a hybridization reaction between at least a first nucleic acid 
probe and its cognate nucleic acid target present in fluid 
solvent, comprising: 
detecting the detectable signal. 
fluid solvent. 
a device, the device comprising: 
at least one substrate; 
a first plurality of identical displacement nucleic acid 
strands; and 
a first plurality of identical docking nucleic acid 
strands, 
wherein the displacement strands and the docking 
strands are immobilized to one of said at least one 
substrates, said immobilized displacement strands 
and said immobilized docking strands being spatially 
segregated from one another, separately addressable, 
and fluidly communicating upon contact of said 
device with fluid solvent; and 
a composition comprising probe nucleic acid strands, the 
probe nucleic strands having at least three regions, 
a first region that is substantially complementary to a 
region of each of the displacement strand, the target, 
and the docking strand; 
a second region that is substantially complementary to 
a region of each of the target and the docking strand, 
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but not substantially complementary to a region of 33. The kit of claim 31, further comprising reagents for 
the displacement strand; and detectably labeling the probe strands of said composition. 
a third region that is substantially complementary to a 34. The kit of claim 31, further comprising a control 
region of the docking strand, but not substantially composition, said composition comprising target nucleic 
complementary to a region of either of the displace- s acids capable of catalyzing transfer of said probes from said 
ment strand or the target. displacement strands to said docking strands. 
32. The kit of claim 31, wherein said probe strands are 
detectably labeled. * * * * *  
